Mercury Biopharmaceutical Corporation (TPEX:6932)
Taiwan · Delayed Price · Currency is TWD 8.68
-0.36 (-3.98%)
Aug 12, 2025, 1:57 PM CST
Paramount Global Market Cap
Mercury Biopharmaceutical has a market cap or net worth of 3.81 billion as of August 11, 2025. Its market cap has decreased by -40.47% in one year.
Market Cap
3.81B
Enterprise Value
3.63B
Revenue
4.96M
Ranking
n/a
PE Ratio
n/a
Stock Price
$8.68
Market Cap Chart
Since December 23, 2022, Mercury Biopharmaceutical's market cap has decreased from 5.10B to 3.81B, a decrease of -25.28%. That is a compound annual growth rate of -10.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2025 | 3.81B | -30.64% |
| Dec 31, 2024 | 5.50B | -29.32% |
| Dec 29, 2023 | 7.78B | 94.15% |
| Dec 30, 2022 | 4.01B | -21.50% |
| Dec 23, 2022 | 5.10B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 203.96B |
| PharmaEssentia | 169.97B |
| Bora Pharmaceuticals Co., LTD. | 88.98B |
| Lotus Pharmaceutical | 57.98B |
| Oneness Biotech | 31.13B |
| Polaris Group | 27.31B |
| Center Laboratories | 27.03B |
| Pegavision | 24.34B |